Patients often assume insurance is automatically the cheaper path. Sometimes it is. Sometimes a high deductible, a non-participating carrier, or a prior-authorization queue makes the stated self-pay price both cheaper and faster. The right answer depends on four things you can check in ten minutes.
One: is your carrier accepted here
Most major carriers are accepted, but not all Maryland plans participate, and some patients discover this only at check-in. Our insurance pages list the common carriers with plain notes on each, and the intake form flags a non-participating carrier immediately so you can decide before you arrive rather than after.
Two: where you are in your deductible
If your deductible resets in January and it is March, an insured visit early in the year is often billed close to full allowed cost anyway. In that situation the stated $175 self-pay evaluation may be the lower and more predictable number. Later in the year, once a deductible is met, insurance usually wins.
Three: how quickly you need to be seen
Self-pay skips authorization steps entirely. For patients who need an evaluation this weekend rather than after a referral and an authorization cycle, that timing difference is the deciding factor.
Four: what comes after the evaluation
The evaluation is one line item. Imaging, injections, therapy courses and medications are separate, and insurance matters more for those than for the first visit. Many patients start self-pay for the evaluation and then use insurance for downstream care, which is entirely allowed.
What does not change either way
The clinical visit is identical. Same clinician time, same examination, same individualized plan, same seven-day and evening telehealth availability. Payment route does not alter care, and no outcome is promised on either path.
If you are unsure, put your carrier into the intake form and let the qualification step tell you where you stand, or call the clinic and ask directly.